SER

Stock ticker: ASE

PRICE

CHANGE

CAPITALIZATION

Serina Therapeutics (SER) Ownership - Who owns Serina Therapeutics?

Serina Therapeutics Inc is a clinical-stage biotechnology company developing a pipeline of wholly-owned drug product candidates to treat neurological diseases and pain... Show more

Get AI intraday signals

#MovingAverage #Momentum #MACD #Pattern #RSI #Stochastic #Aroon #Bollinger

Profile

Industry

N/A

Address

601 Genome Way

Phone

+1 256 327-0566

Employees

N/A

Web

https://www.serinatherapeutics.com

Details

Group

Domestic Stock Funds

Fundamentals

SER

Capitalization

52.1M

P/E Ratio

30.60

Risk (Beta)

N/A

Dividend Yield

N/A

Total Cash

3.19M

Total Cash/Share

0.32

Total Debt

11.5M

Total Debt/Equity

N/A

Projected Growth (PEG Ratio)

N/A

Revenue/Share (as % of the share price)

Revenue

N/A

ROE

N/A

Book Value

-13.77M

P/B Ratio

81.30

Cash Flow

N/A

Earnings

N/A

Average Daily Volume YTD

N/A

Common Shares Outstanding - Security Level

Current Ratio

0.40

Current Revenue Per Employee

N/A

Dividends Per Share - Security

N/A

EBITDA

N/A

Float

N/A

Float - Current

N/A

Gross Income Margin

N/A

Revenue To Assets

N/A

Shares Held By Institutions

2.03M

Shares Outstanding - Current

9.93M

Total Liabilities

21.3M

Total Volume MTD

N/A

Value

-1

Gain YTD

4.790

View a ticker or compare two or three

Compare

Ad is loading...

A.I.Advisor

published price charts

A.I. Advisor

published General Information

General Information

Industry Biotechnology